Progyny CEO Peter Anevski sells $6.18 million in company stock
At a glance
- $PGNY today−1.18%last $36.71
- Vs industry peers+2.25 pts6-peer median −3.43% · far ahead
- Since Nov 9+2.00%from the first trade after the story
- 52-week range1.3% below high$16.10 – $37.20
- Last reported profit$26.3Mquarter to Sep 30, 2026 · 10-Q
- In the headline$6.18 millionAmount
Nothing reported about progyny across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: The headline zeroes in on one number — $6.18 million — but the real story lies in what came before and what might come next.
- How the stock is trading: $PGNY -1.18% in the latest session.
- Timing: It came out outside trading hours; the change shown is from the previous, already closed session. Market holidays are not detected.
Where the stock stands
Progyny ($PGNY) slipped 1.18% to $36.71 in the latest session. Over the past month it is up 31.9%. It now sits 1.3% under the 52-week high of $37.20 and 128% above the year's low of $16.10, close to the top of its range. The year's high was 2.3 times its low, which makes double-digit swings fairly routine here.
What the filings say
In its latest report (10-Q, filed Nov 5, 2026), $PGNY earned $26.3M over the quarter to Sep 30, 2026 on revenue of $341.3M (-2.6% QoQ). Operations brought in $153.0M of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was $131.0M. Total liabilities were $261.8M against $116.8M of cash on Sep 30, 2026. Its most recent filings before this story: 10-Q on Nov 5, 2026, 8-K on Nov 4, 2026, 10-Q on Aug 7, 2026. Figures are as filed with the SEC; the $PGNY page has the full statements.
How much coverage it is getting
Wook has filed 4 stories on Progyny in the last 30 days, 1 of them this week. Its 30-day average is about 1 a week, so this week is a normal week for it. Going by their wording, 0 read bullish, 4 neutral and 0 bearish. This one reads neutral, like most of them. Investing.com wrote 3 of the 4 (75%), so the count reflects one outlet's output more than broad attention.
The bigger picture
In healthcare, timing is everything — trial results, FDA rulings, and pricing shifts can turn a stock's direction in an instant. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
For the company's side of it, read its latest SEC filings on the $PGNY page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Most of the recent coverage comes from one outlet, so check whether another newsroom has confirmed the story or is only repeating it. Wook AI, at the top of the page, can work out how far $PGNY is from its high or compare this week's coverage with earlier weeks.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 10, 2026. $PGNY has moved +2.00% ($35.99 to $36.71). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
